Baotou Dongbao Bio-Tech Co Ltd (300239) — Strategic Asset Allocation Index
Baotou Dongbao Bio-Tech Co Ltd (300239) has a Strategic Asset Allocation Index of 59.1% as of June 2023. Strategic assets (PP&E of CN¥1.07 Billion plus long-term investments of CN¥-) total CN¥1.07 Billion, measured against net assets of CN¥1.81 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 300239 net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Baotou Dongbao Bio-Tech Co Ltd Strategic Asset Allocation Index (2008–2022)
This chart shows how Baotou Dongbao Bio-Tech Co Ltd's Strategic Asset Allocation Index has evolved across 15 annual periods from 2008 to 2022. As of June 2023, the index stands at 59.1%, representing strategic assets of CN¥1.07 Billion against net assets of CN¥1.81 Billion CNY. For live market cap and overall valuation, see market value of Baotou Dongbao Bio-Tech Co Ltd.
Annual Strategic Asset Allocation Index for Baotou Dongbao Bio-Tech Co Ltd (2008–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Baotou Dongbao Bio-Tech Co Ltd from 2008 to 2022, covering 15 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Baotou Dongbao Bio-Tech Co Ltd (300239) shareholders funds for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 58.0% | CN¥1.02 Billion | CN¥1.02 Billion | CN¥- | CN¥1.76 Billion | ▼ -2.3 pp |
| 2021 | 60.3% | CN¥966.90 Million | CN¥966.90 Million | CN¥- | CN¥1.60 Billion | ▼ -21.1 pp |
| 2020 | 81.4% | CN¥812.04 Million | CN¥812.04 Million | CN¥- | CN¥998.18 Million | ▲ +6.5 pp |
| 2019 | 74.9% | CN¥742.71 Million | CN¥742.71 Million | CN¥- | CN¥991.86 Million | ▼ -11.1 pp |
| 2018 | 86.0% | CN¥645.47 Million | CN¥636.73 Million | CN¥8.74 Million | CN¥750.88 Million | ▲ +6.4 pp |
| 2017 | 79.6% | CN¥580.62 Million | CN¥574.81 Million | CN¥5.80 Million | CN¥729.75 Million | ▲ +20.4 pp |
| 2016 | 59.2% | CN¥425.56 Million | CN¥421.47 Million | CN¥4.09 Million | CN¥718.86 Million | ▲ +26.2 pp |
| 2015 | 33.0% | CN¥233.13 Million | CN¥233.13 Million | CN¥- | CN¥706.55 Million | ▼ -28.3 pp |
| 2014 | 61.3% | CN¥208.63 Million | CN¥208.63 Million | CN¥- | CN¥340.56 Million | ▼ -1.0 pp |
| 2013 | 62.3% | CN¥218.88 Million | CN¥218.88 Million | CN¥- | CN¥351.47 Million | ▼ -4.1 pp |
| 2012 | 66.4% | CN¥215.03 Million | CN¥215.03 Million | CN¥- | CN¥324.03 Million | ▲ +9.2 pp |
| 2011 | 57.2% | CN¥169.26 Million | CN¥169.26 Million | CN¥- | CN¥295.99 Million | ▼ -43.9 pp |
| 2010 | 101.1% | CN¥123.80 Million | CN¥123.80 Million | CN¥- | CN¥122.44 Million | ▼ -18.2 pp |
| 2009 | 119.3% | CN¥120.11 Million | CN¥120.11 Million | CN¥- | CN¥100.65 Million | ▲ +7.5 pp |
| 2008 | 111.8% | CN¥109.44 Million | CN¥109.44 Million | CN¥- | CN¥97.87 Million | — |